RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kindred Biosciences - Stock

Kindred Biosciences Stocks 2024

Kindred Biosciences Stocks

39.29 M

Ticker

KIN

ISIN

US4945771099

WKN

A1XA6K

In 2024, Kindred Biosciences had 39.29 M outstanding stocks, a 0% change from the 39.29 M stocks in the previous year.

The Kindred Biosciences Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2024e39.29
2023e39.29
2022e39.29
2021e39.29
202039.29
201938.66
201831
201725.08
201619.87
201519.77
201418.78
20133.73
201213.3

Kindred Biosciences shares outstanding

The number of shares was Kindred Biosciences in 2023 — This indicates how many shares 39.29 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Kindred Biosciences earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Kindred Biosciences's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Kindred Biosciences’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Kindred Biosciences's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Kindred Biosciences Aktienanalyse

What does Kindred Biosciences do?

Kindred Biosciences Inc. is a biopharmaceutical company that was founded in 2012 by Richard Chin, an experienced pharmaceutical entrepreneur. The company's goal is to develop and bring to market innovative animal medicines for pets. The business model of Kindred Biosciences is based on the identification and development of novel, safe, and effective animal medicines for dogs, cats, and horses. The company utilizes state-of-the-art technologies and research methods to develop high-quality products that meet the needs of veterinarians and pet owners. The company currently has three main business segments: biologics, biopharmaceuticals, and small molecules. Each of these segments focuses on specific animal diseases and offers a unique range of products. The biologics segment of Kindred Biosciences develops innovative vaccines for dogs and cats that are highly effective and have improved tolerability. Kindred Biosciences' vaccines are specifically tailored to the needs of pets and can help prevent infections and diseases in dogs and cats. The biopharmaceuticals segment of Kindred Biosciences develops novel therapies for chronic diseases in dogs and cats, such as chronic pain, inflammation, and cancer. The company utilizes state-of-the-art technologies and research methods to develop effective and safe therapies that meet the needs of veterinarians and pet owners. The small molecules segment of Kindred Biosciences develops novel drugs for horses that are highly effective and have improved tolerability. Kindred Biosciences' drugs are specifically tailored to the needs of horses and can help treat various conditions such as arthritis or colic. The company has a broad range of products, currently consisting of over a dozen products that focus on different animal species, diseases, and needs. These include therapies for chronic pain, inhalation anesthetics, drugs for cancer and inflammation, as well as vaccines for various infections. Kindred Biosciences has achieved significant success in recent years. The company has conducted numerous clinical trials and brought several drugs and vaccines to market. In 2018, the company received approval from the Food and Drug Administration (FDA) for a groundbreaking therapy for chronic pain in dogs. The company also has a strong pipeline of products in development that could contribute to supporting the company's growth in the coming years. In summary, Kindred Biosciences is an innovative biopharmaceutical company focused on the development and commercialization of innovative animal medicines. The company has a broad range of products and is capable of developing high-quality products for a variety of animal species, diseases, and needs. With a strong pipeline and a successful track record, Kindred Biosciences is well-positioned to solidify its leading position in the industry and accelerate its growth in the coming years. Kindred Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Kindred Biosciences's Shares Outstanding

Kindred Biosciences's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Kindred Biosciences’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Kindred Biosciences’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Kindred Biosciences’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Kindred Biosciences Stock

How many stocks are there of Kindred Biosciences?

The current number of stocks of Kindred Biosciences is 39.29 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Kindred Biosciences are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Kindred Biosciences evolved in recent years?

The number of shares of Kindred Biosciences has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Kindred Biosciences as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Kindred Biosciences?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Kindred Biosciences pay?

Over the past 12 months, Kindred Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Kindred Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Kindred Biosciences?

The current dividend yield of Kindred Biosciences is .

When does Kindred Biosciences pay dividends?

Kindred Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Kindred Biosciences?

Kindred Biosciences paid dividends every year for the past 0 years.

What is the dividend of Kindred Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Kindred Biosciences located?

Kindred Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kindred Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kindred Biosciences from 7/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/1/2024.

When did Kindred Biosciences pay the last dividend?

The last dividend was paid out on 7/1/2024.

What was the dividend of Kindred Biosciences in the year 2023?

In the year 2023, Kindred Biosciences distributed 0 USD as dividends.

In which currency does Kindred Biosciences pay out the dividend?

The dividends of Kindred Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Kindred Biosciences stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Kindred Biosciences

Our stock analysis for Kindred Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kindred Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.